Journal profile · ENGINEERING, BIOMEDICAL

APL Bioengineering

ISSN 2473-2877 · AIP Publishing LLC · United States

APL Bioengineering: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 4.83; fully open access; APC about USD 2,750; median 122 days to acceptance (102 articles, last 24 months); 103 articles in 2025; indexed in SCIE and Scopus.

Impact factor4.83Latest value listed by LetPub
CAS zoneZone 3 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 3 · Medicine
Review time122 daysMedian, submission to acceptance · 102 articles, last 24 months · PubMed
APCUSD 2,750Fully open access
Acceptance—No reports yet
Articles per year1032025 · OpenAlex count

Scope

Aims, scope and focus

APL Bioengineering is published by AIP Publishing LLC and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are 3D Printing in Biomedical Research, Cellular Mechanics and Interactions and Cancer Cells and Metastasis, together about 40.8% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

Research area (LetPub): ENGINEERING, BIOMEDICAL

Editor-in-chief Justin Cooper-WhitePublisher website

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. 3D Printing in Biomedical ResearchEngineering20.4%
  2. Cellular Mechanics and InteractionsBiochemistry, Genetics and Molecular Biology13.7%
  3. Cancer Cells and MetastasisMedicine6.7%
  4. Microfluidic and Bio-sensing TechnologiesEngineering6.2%
  5. Neuroscience and Neural EngineeringNeuroscience5.8%
  6. Tissue Engineering and Regenerative MedicineMedicine4.7%
  7. Electrospun Nanofibers in Biomedical ApplicationsMaterials Science4%
  8. Pluripotent Stem Cells ResearchBiochemistry, Genetics and Molecular Biology3.6%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
LevelCategoryZone
MajorMedicineZone 3
MinorEngineering, BiomedicalZone 3

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
LevelCategoryZone
MajorMedicineZone 3
MinorEngineering, BiomedicalZone 3

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
LevelCategoryZone
MajorMedicineZone 3
MinorEngineering, BiomedicalZone 3

Top journal: noReview journal: no

Database indexing

SCIEScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
4.83LetPub ·
CiteScore 2026-06
6.6LetPub ·
SJR 2026-06
1.1LetPub ·
SNIP 2026-06
0.94LetPub ·
h-index
55OpenAlex ·
i10-index
316OpenAlex ·
2-year mean citedness
6.55OpenAlex ·
Self-citation rate
6.1%LetPub ·
Share of gold OA articles
100%LetPub ·

Volume

Articles per year
100LetPub ·

Articles by year OpenAlex count · 610 in total · the current year is incomplete

YearArticlesOpen accessCitations
2026484856
2025103103542
20241021021,059
202386861,384
202244441,046
202174742,924

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with PubMed · to

122 daysMedian, submission to acceptance · P25–P75 95 days – 158 days

Acceptance to online
median 21 days (102 articles)
Submission to online
median 143 days
Sample
102 articles with submission and acceptance dates (170 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
about 19 weeksLetPub ·
Submission to publication (journal-reported)
about 19 weeksDOAJ ·
Peer review
Unspecified peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessDOAJ

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
DOAJUSD 2,750NoCC BY
OpenAlexUSD 2,200——
LetPubUSD 2,200Yes—

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher
AIP Publishing LLC
Country or region
United States
Language
English
ISSN
2473-2877
Official links

FAQ

Frequently asked questions about APL Bioengineering

What CAS zone is APL Bioengineering in?

In the 2025 upgraded edition of the CAS Journal Ranking, APL Bioengineering is in Zone 3 of Medicine, and in Zone 3 of the minor category Engineering, Biomedical. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of APL Bioengineering?

The latest impact factor listed by LetPub is 4.83; CiteScore 6.6, h-index 55.

How long does peer review take at APL Bioengineering?

Based on the dates recorded on 102 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 122 days (interquartile range 95–158 days); authors report an average review time of about 19 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index APL Bioengineering?

According to LetPub and DOAJ records, APL Bioengineering is indexed in SCIE, Scopus and DOAJ.

Is APL Bioengineering open access, and what is the APC?

APL Bioengineering is a fully open-access journal. APC about USD 2,750.

Sources and updates

The facts on this page come from LetPub, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .